DataMeds AI MEDS
NASDAQ MEDS
$0.85 -0.02 (-2.31%)
At close: Sep 9, 2026 · 4:00 PM EDT

DataMeds AI (MEDS) Price to Book (2025 - 2026)

DataMeds AI's (MEDS) quarterly Price to Book came in at 0.76 in Q1 2026, down 101.28% on a YoY basis from 59.28 in Q1 2025, and up 66.64% quarter-over-quarter from 2.28 in Q4 2025.

Analysis

DataMeds AI (MEDS) Price to Book (2025 - 2026) Analysis & Trends

DataMeds AI (MEDS) has reported Price to Book for 2 consecutive years, with 0.76 the latest figure, recorded in Q1 2026.

  • For the quarter ending Q1 2026, Price to Book fell 101.28% year-over-year to 0.76; the trailing twelve-month figure through Mar 2026 stood at 0.76 (down 101.28% YoY), and the FY2025 full-year result was 2.28, changed N/A from the prior year.
  • Price to Book improved to 0.76 in Q1 2026 per MEDS's latest filing, from 2.28 in the prior quarter.
  • Across five years, Price to Book topped out at 67.59 in Q2 2025 and bottomed at 2.28 in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Mckesson 106.22 Bn 101.06 Bn 3.69 Bn
2 Cencora 62.63 Bn 59.81 Bn 3.61 Bn
3 Cardinal Health 56.55 Bn 51.69 Bn 2.56 Bn
4 Henry Schein 9.98 Bn 9.82 Bn 1.10 Bn
5 ZeroStack 42.33 Mn 39.37 Mn 1.62 Mn
6 111 27.24 Mn -27.13 Mn 18.18 Mn
7 Guardian Pharmacy Services 5.51 Mn -84.30 Mn 80.04 Mn
8 Ridgetech 4.71 Mn -13.30 Mn -
9 MedWellAI 2.27 Mn 2.28 Mn -
10 DataMeds AI 1.78 Mn 1.73 Mn 170,221.00
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 -0.76
Dec 31, 2025 -2.28
Sep 30, 2025 9.73
Jun 30, 2025 67.59
Mar 31, 2025 59.28